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ABSTRACT
Extra-intestinal pathogenic Escherichia coli (ExPEC) strains are divided into uropathogenic E. coli (UPEC), strains causing 
neonatal meningitis and septicaemic E. coli. The most common pathotype of ExPEC is found among patients with urinary 
tract infection (UTI), defined as UPEC. These bacteria are responsible for >90% of cases of UTI and are often found amongst 
the faecal flora of the same host. E.coli strains are classified into four phylogenetic groups, A, B1, B2, and D. Groups A 
and B1 are commensal strains and carry few virulence-associated genes (VGs) while pathogenic group B2 and D usually 
possess VGs which enhance colonic persistence and adhesion in the urinary tract (UT). The gastrointestinal (GI) tract is 
widely accepted as a reservoir for UPEC and is believed that healthy humans have a reservoir of UPEC strains, belonging to 
phylogenetic group B2, and to a lesser extent, group D. These strains have superior ability to survive and persist in the gut 
of humans and can spread to cause extra-intestinal infections. ExPEC trains possess a range of VGs which are involved in 
their pathogenesis. These include adhesins, toxins, iron-acquisition systems (e.g. siderophores), and capsules. Evolutionary 
influences on the acquisition and main role of VGs amongst E. coli are widely debated, with some research holding that the 
prevalence of strains with VGs increases the likelihood of infections, whereas others believe that VGs provide a selective 
advantage for infection of extra-intestinal sites. This review is intended to present our existing knowledge and gaps in this area.
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OVERVIEW  Of  gASTROInTESTInAL  TRACT 
The  body  is  protected  from  the  external 
environment by the intact epithelial layer  (1). The 
GI  tract  provides  a  barrier  between  the  external 
environment  and  sterile,  internal  organs,  whilst 
allowing  absorption  of  essential  nutrients.  The  GI 
system extends from the mouth and oesophagus to the 
rectum and can be divided into the upper (mouth and 
stomach) and lower tracts (small and large intestine) 
(2). Bacteria colonise the GI tract immediately after 
birth to form a complex milieu constituting hundreds 
of bacterial species, most of which are residing in 
the  lower  intestine.  This  flora  develops  through  a 
process of ecological succession and has tremendous 
role in the state of health and disease. Among the 
important factors in this process is the influence of 
the intestinal physiology on the interaction between 
the microorganisms that contaminate the host, diet 
regime and food composition, immunological status 
of the host and the environment (3). The GI tract is 
composed  of  four  layers:  the  mucosa,  submucosa, 
muscularis  externa  and  serosa  (4,  5).  The  mucosa 
is  the  external  layer  of  the  epithelium,  which  is 
constantly exposed to bacteria (1, 4, 5). 
The  intestinal  epithelium  is  more  than  just  a 
physical barrier protecting internal body sites, with 
immune interactions to prevent infection and disease 
from constant exposure to bacteria (6). In the lower 
GI tract, bacteria must overcome host defences such 
as peristalsis, lysozyme secretions, intestinal mucus, 
and gut-associated lymphoid tissue (1, 7). Epithelial 
cells  are  protected  by  a  layer  of  mucus  and  other 
nonspecific host defences, as well as a diverse range 
of mainly commensal bacteria (8). Mucous is secreted 
by goblet cells and acts as a lubricant for the smooth 
passage of food and faecal matter along the GI tract. 
It also helps to trap bacteria, preventing adherence 
to the GI epithelial cells (1, 6). The lower GI tract 
has a high rate of cell turnover, constantly shedding 
epithelial cells and many bacteria which have been 
able to adhere (6). These host defences help to prevent 
and decrease bacterial adhesion and colonisation in 
the lower GI tract. 
Keywords:  E.coli,  Urinary  tract  infection,  Gut, 
Virulence factors, Gastro-intestinal (GI).
InTESTInAL  MICROfLORA
The  large  intestine  supports  the  growth  of 
commensal bacteria known as intestinal microflora. 
In the large intestine, these bacteria interact with, and 
colonise the epithelial cells. These bacteria survive 
within the GI tract, receiving nutrients from the host, 
whilst providing the host with essential nutrients and 
benefits (6). Intestinal microflora normally persists 
for long periods of time and their population size, 
depending on the species, can vary between 108 and 
1012 bacteria per gram of colon contents (9). Major 
bacterial species/genus that inhabit the large intestine 
are  Bifiobacterium,  Bacteroides,  Lactobacillus, 
Clostridium,  Fuscobacterium  and  Enterobacteria 
(2).  It  is  well  established  that  a  stable  intestinal 
microflora  can  prevent  the  growth  of  pathogenic 
strains which have survived the gastric juice of the 
upper GI tract and have reached the large intestine 
(1,  7,  10).  Intestinal  microflora  has  an  important 
role in preventing intestinal diseases by competitive 
inhibition of pathogenic strains, and due to a high 
number of bacteria and their functions it has been 
referred  to  as  an  organ  of  the  body  (3).  Intestinal 
microflora has three main functions and effects on 
the mucosa: protective, structural, and metabolic (1, 
3). It provides a protective function by competition 
with pathogens for nutrients and receptors within the 
GI tract. Some strains of this flora, such as lactic acid 
bacteria, produce bacteriocins and lactic acid which 
inhibit the growth of other bacterial species (1). The 
metabolic functions of this flora include the synthesis 
of essential vitamins such as biotin and folate, and 
fermentation of non-digestible dietary residues (3). 
Whilst  the  GI  tract  has  many  protective  functions 
to  prevent  adherence  of  pathogenic  strains,  some 
functions encourage the growth of bacteria. The mucus 
layer contains mucins which produce saccharides that 
are utilised as a source of energy by commensal and 
pathogenic strains (8).
Many factors can impact homeostasis of intestinal 
microflora such as changes in diet, physical stressors, 
and  degenerative  and  infectious  diseases  (10,  11). 
Food has been identified as a source for new bacterial 
species to enter the body and persist as microflora 
(12). Common foods such as yoghurt contain healthy 
bacteria known as probiotics, which have a protective 
role in the gut (13).  Bifidobacteria are also common gut 
species with a protective role however, elderly males 
and females have shown to have lower populations 
of these protective bacteria than younger adults (14). 
Molecular based approaches have identified a shift 
in dominant microflora species amongst the elderly 61 ExtEraintEstinal  E.coli
population  towards  a  greater  diversity  of  bacterial 
species  than  younger  adults  and  children  (15). 
Furthermore, fewer species isolated from elderly are 
able to be cultivated (15). Under certain conditions 
some of these bacteria are able to cause disease of 
extra-intestinal sites (3, 15). A common commensal 
GI tract bacterium responsible for many intestinal and 
extraintestinal infections is Escherichia. coli (16).
E. coli 
E. coli is commonly found in the large intestine of 
humans and other warm-blooded animals (2). These 
strains can be commensal, existing in a symbiotic state 
providing  resistance  against  pathogenic  organisms, 
or be pathogenic and cause diseases of intestinal and 
extra-intestinal sites (6).  E. coli is found in relatively 
lower numbers than other major commensal bacteria; 
however, it is the most common cause of intestinal 
and  extra-intestinal  disease  (10).  The  pathogenic 
strains of E. coli may carry several virulence factors 
directly involved in pathogenesis of these bacteria, 
although commensal strains may also cause disease 
in immunocompromised hosts (10, 17). 
Phylogenetic groups of E. coli
Commensal  and  pathogenic  E.  coli  can  be 
collectively classified into four different phylogenetic 
groups; A, B1, B2, and D (18). Phylogenetic groups 
A and B1 mainly consist of commensal strains found 
in the large intestine of humans and animals, as well 
as in environmental samples (19). These strains do not 
normally carry any known virulence factors (20). In 
contrast, phylogenetic group B2, and to a lesser extent, 
group D, consist of pathogenic strains and normally 
carry  virulence-associated  genes  (VGs)  that  are 
mostly  associated  with  extra-intestinal  diseases  (18, 
20). Some reports indicate that strains belonging to 
phylogenetic groups A and B1 can also cause disease 
of extra-intestinal sites (19), although this has not been 
consistently  supported  (21).  A  recent  phylogenetic 
group  E  has  also  been  identified,  however  it  is 
uncommon, and is not widely used (22, 23). This group 
shares alleles with many E. coli strains and includes the 
enterohaemorragic strain O157:H7 (22). Pathogenic E. 
coli strains can cause three major types of infections: 
(i) enteric or diarrhoeagenic disease, (ii) UTI, and (iii) 
blood infection or sepsis and meningitis (24, 25).
diarrhoeagenic E. coli
Diarrhoea is more common in developing countries 
and children under five due to poor sanitation and 
hygiene  (26,  27).  Intestinal  pathogenic  E.  coli  are 
responsible  for  majority  of  these  cases  worldwide 
(25).  E.  coli  that  cause  disease  of  the  intestinal 
tract are referred to as diarrhoeagenic E. coli (25).   
Diarrhoeagenic  E.  coli  strains  rarely  translocate 
the  GI  epithelium  and  their  pathogenic  affect  is 
mostly  restricted  to  pathophysiological  changes 
of  the  intestinal  epithelial  cells  (6).  The  major 
pathotypes  are  enterotoxigenic  E.  coli  (ETEC), 
enteropathogenic E. coli (EPEC), enteroinvasive E. 
coli  (EIEC),  enterohaemorrhagic  E.  coli  (EHEC), 
enteroaggregative E. coli (EAggEC), and diffusely 
adherent  E.  coli  (DAEC)  (25).  Since  this  review 
focuses on ExPEC strains, the mechanisms by which 
diarrhoeagenic  strains  of  E.coli  cause  intestinal 
infection will be briefly discussed here.   
Unlike commensal E. coli, diarrhoeagenic strains 
carry specific surface adhesins which enhance their 
ability  to  colonise  the  GI  tract.  Once  established 
in  the  GI  tract,  the  six  pathotypes  vary  in  their 
disease patterns and intensity (25). ETEC is known 
as  traveller’s  diarrhoea,  and  like  many  other 
diarrhoeagenic  strains,  it  is  associated  with  poor 
hygiene. ETEC strains produce two toxins, a cholera-
like toxin called heat-labile toxin (LT), and a peptide 
hormone-like  toxin  called  heat-stable  toxin  (ST) 
(6,  25).  EPEC  strains  express  bundle  forming  pili 
(BFP) which are involved in bacterium-to-bacterium 
adhesion  and  promotes  the  formation  of  bundles. 
These structural changes cause diarrhoea through the 
loss  of  absorptive  capacity.  EAggEC  strains  cause 
persistent diarrhoea in children which is believed to be 
caused by an unidentified diarrhoeal toxin, EAggEC 
heat-stable enterotoxin 1 (EAST1) (28). EHEC strains 
bind to mucosal cells through actin reorganisation as 
seen with EPEC strains. These strains produce Shiga-
like  toxin,  with  receptors  found  on  intestinal  cells 
and in the kidney, which can lead to kidney failure 
known as haemolytic uraemic syndrome (25). 
EIEC is the only invasive pathotype, penetrating 
epithelial cells in an endocytic vesicle. These strains 
lyse  vesicles  to  multiple  within  cells  and  then 
move through the cytoplasm to adjacent epithelial 
cells (29). Active invasion of colonic cells causes 
bloody  diarrhoea.  The  most  recent  pathotype  is 
DAEC which binds to the small bowel in a diffuse 
adhesion pattern, however there is limited research 
on the exact mechanism of action of this pathotype 
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Other virulent strains of E. coli may cause a large 
range of diseases outside the GI tract (31). These 
pathotypes are referred to as ExPEC and are divided 
into UPEC which is the most common pathotype 
of ExPEC found among patients with UTI, strains 
causing neonatal meningitis and septicaemic E. coli 
(32). 
urinary tract infection
UTI  is  one  of  the  most  common  diseases 
worldwide. Although it is one of the easiest treatable 
diseases,  it  may  cause  serious  complications  in 
healthy  individuals  if  not  optimally  treated,  with 
many women experiencing recurrent episodes (32). 
UTI has been defined as the presence of  significant 
numbers of pathogenic bacteria or organisms in the 
urinary system, depending on the presence or absence 
of symptoms while recurrent UTI can be defined as 
two or more episodes within 6 months or three or 
more episodes within 12 months (33). UTIs are more 
common among females, with up to 60% of women 
having  at  least  one  episode  in  their  lifetime  (34). 
The  disease  is  the  most  frequent  hospital-acquired 
infection, affecting mainly women, children, and the 
elderly  (35).  Factors  such  as  shortness  of  urethra, 
sexual activity, contraceptives, estrogen deficiency, 
diabetes, obstructing lesions, and genetic factors such 
as blood group secretor status increase a woman’s 
likelihood of contracting UTI (33, 36).
The lower GI tract is a common source of UTI 
causing bacteria, with some strains able to colonise the 
vagina (37-40). The UTI-causing strains have certain 
VGs  that  distinguish  them  from  other  commensal 
E.coli of the gut. These strains often originate from 
the stool where they enter the UT via colonisation of 
the vaginal introitus and the periuretheral area (6). 
Bacteriuria is the presence of these bacteria in the UT 
when the patient has no physical symptoms normally 
associated with UTI such as pain, frequency and 
urgency (24). Under these conditions, E. coli strains 
exist in an asymptomatic carrier state without any 
obvious symptoms of UTI (41). E. coli strains that 
colonise  the  UT  may  ascend  towards  bladder  to 
cause cystitis, which is usually associated with the 
classic symptoms of UTI, i.e. pain, frequency, and 
urgency.  UTI  can  proceed  from  the  bladder,  via 
the ureters to the kidney, to cause pyelonephritis, 
with the possibility of causing irreversible kidney 
damage leading to kidney failure and death (42).
UPEC  strains  have  VGs  that  distinguish  them 
from  other  strains.  Some  of  these  VGs  such  as 
adhesins are essential for initiating infection in the 
host, whereas others (e.g. toxins) are responsible 
for  damaging  the  host  to  benefit  the  bacterium. 
In UPEC strains adhesion is vitally important to 
overcome host defences in the UT and resist the 
flushing  effect  of  the  urine  (6).  UPEC  can  also 
carry  VGs  important  for  survival  in  body  sites 
lacking essential metabolites, such as mechanisms 
for  acquiring  iron. Although E.  coli  is  the  most 
common cause of UTI, responsible for >90% of 
cases in young adults (37), and >60% of cases in 
elderly individuals (43), in chronic and complicated 
UTIs bacterial strains are often mixed (44).
BACTERIAL  PERSISTEnCE 
Women with UTIs that are not optimally treated, 
have up to 44% chance of recurrence of infection 
within 12 months (33). A recent study has found 67% 
of recurrent UTIs were caused by the same E. coli 
strain (37). This and many other results suggest a 
reservoir for these strains that enable them to cause 
recurrent infections (38, 39, 45). The former study 
has also found that the infecting strains for recurrent 
UTI  to  be  present  in  the  faecal  flora  of  78%  of 
women, however the dominance of these clones was 
not reported (38). Moreno and co workers found 30 
out of 42 patients carried a UTI-causing strain as the 
dominant  faecal  clone,  however  persistence  of  the 
strain in the GI tract was not measured (38). These 
findings reinforce the importance of faecal flora as a 
major reservoir for UTI-causing strains. In the case 
of recurrent UTI it is also shown that the responsible 
E. coli strains may protect themselves from the effect 
of antibiotics by hiding in the bladder cells. Using a 
mouse model of UTI it has been suggested that E. coli 
lie dormant within the bladder mucosa (46).
ExPEC strains causing septicaemia
Septicaemia is the presence of microorganisms in 
the blood (6). ExPEC strains are the most common 
group  of  microorganisms  that  cause  septicaemia. 
They may enter the blood through open wounds and 
burns, or may translocate from the kidney or GI tract, 
a process called bacterial translocation (47). Severe 
septicaemia is known as sepsis and is associated with 
increased morbidity and mortality (48). Septicaemia 
which  has  originated  from  the  UT  is  known  as 
urosepsis (49, 50). From the blood, ExPEC strains can 63 ExtEraintEstinal  E.coli
infect distant organs, causing multiple organ failure 
and  shock  (51).  A  recent  study  investigating  the 
virulence of septicaemic E. coli strains has indicated 
these strains may carry a repertoire of VGs ranging 
from adhesins to iron acquisition system (52).
ExPEC strains causing meningitis
Meningitis is inflammation of the protective layers 
of the brain and spinal cord (53).  It is a life threatening 
infection more commonly associated with neonates, 
and to a lesser extent, immunocompromised children 
and adults (54). The diseases now-a-days, is commonly 
caused by E. coli. Infection of the meninges differs 
from other body site attributable to the necessity for 
strains to cross endothelial cells which form the blood 
brain  barrier.  Meningitis-associated  E.  coli  have 
acquired VGs to cross the blood brain barrier, most 
commonly K1 capsule polysaccharide and S-fimbriae, 
which enable E. coli to cross via transcytosis (5, 55). 
K1 capsule also protects the bacterium with serum 
resistance and antiphagocytic properties (54). E. coli 
strains that cause extra-intestinal infections such as 
UTI,  meningitis  and  septicaemia  have  VGs  which 
enable their survival and infection.
VIRuLEnCE  fACTORS  Of  ExPEC
There  are  a  number  of  VGs  that  help  extra-
intestinal E. coli to survive the hostile environment 
of the GI tract and persist in extra-intestinal sites to 
cause  infection.  These  include  adhesins  (e.g.  type 
1 fimbriae and P-pili), toxins (e.g. haemolysin and 
cytotoxic necrotizing factor), polysaccharide capsules 
(e.g. K1 and K5), and siderophores (e.g. iron transport 
systems aerobactin and novel catecholate siderophore 
E. coli). Many of these VGs are controlled by phase-
variable genetic switches that control their expression 
dependant on the environment conditions such as pH, 
osmolarity, temperature and amino acid concentration 
(24, 56). Two of the most studied adhesins amongst 
UPEC are type 1 fimbriae and P-pili.
Type 1 fimbriae
Type  1  fimbriae  are  filamentous  organelles  that 
cover  the  surface  of  the  bacterium  (57).  These 
fimbriae are encoded by the fim gene cluster, with the 
structural components of the fimbriae composed of 
fimA, fimF, fimG, and fimH, and the pilus encoded by 
fimC and fimD (58). fimH is the tip of the pilus which 
mediates    binding  to  glycoproteins  (58,  59).  These 
fimbriae bind to oligosaccharides which are located on 
the cell membrane of body cells, such as epithelial cells.  
Type 1 fimbriae are the most common VG amongst 
UPEC, and are expressed by more than 80-90% of all 
E. coli, including commensal bacteria and pathogens 
(59).  Due  to  the  frequency  of  type  1  fimbriae 
amongst  pathogenic  and  commensal  strains,  it  has 
been concluded that this fimbriae has no correlation 
with  UTI  (24).  On  the other hand,  several studies 
have shown that type 1 fimbriae are crucial during 
the first stages of infection by UPEC and mediate 
binding  to  urethral  epithelial  cells  (57).  Type  1 
fimbriae,  specifically  fimH,  have  also  been  shown 
to have a critical role in activation of mast cells in 
the bladder epithelium, which are an inflammatory 
cell  activated  during  UTI  (57,  60).  Activation  of 
mast cells is associated with the release of histamine, 
which initiates the body’s inflammatory response to 
clear the infection, and is typically associated with the 
symptoms of UTI such as pain and frequency (60). 
Type 1 fimbriae lacking fimH are unable to invade 
bladder cells, emphasizing the importance of fimH for 
establishing infection of the UT (61). Tamm-Horsfall 
protein (THP) coats uroepithelial cells with the main 
role to bind type 1 fimbriae to prevent bacteria from 
adhering to epithelial cells (62). Distribution of THP 
varies throughout the UT which may influence results 
of different research methodologies (24).
UTI  can  proceed  to  the  kidneys  to  cause 
pyelonephritis. THP is abundant within renal epithelial 
cells, which binds to UPEC strains expressing type 
1 fimbriae, to prevent their adherence in the kidney 
(62). Although type 1 fimbriae are clearly important 
for  adhesion  to  the  uroepithelium,  other  VGs  are 
needed  for  subsequent  invasion  of  epithelial  cells 
and  infection.  Expression  of  type  1  fimbriae  is 
coregulated  with  the  expression  of  P-pili  which 
are  associated  with  with  UTI  and  pyelonephritis. 
Bacteria are able to switch the production of VGs on 
or off, depending on the environment and the needs 
of the bacteria, to create many different phenotypes 
(56). Expression of the fim gene cluster is controlled 
by fimS (63, 64) and  is co-regulated with expression 
of P-pili, with each bacterium expressing only one 
at  a  time  (63,  64).  Studies  have  shown  papB  (a 
regulatory protein of P-pili) inhibits the activity of 
fimB and increases fimE activity, both work together 
to inhibit the expression of type 1 fimbriae from being 
switched into the ‘on’ position, hence inhibiting type 
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may  account  for  differential  expression  of  type  1 
fimbriae in different body sites. A review article by 
Johnson (24) has analysed the expression of type 1 
fimbriae and reported expression of similar portions 
in urinary (64%) and faecal strains (60%) with blood 
isolates having an increased expression (80%). These 
findings  collectively  suggest  an  important  role  of 
type 1 fimbriae among septicaemic strains of E.coli 
although  their  exact  mechanism  in  this  process  is 
not known. Much research had been conducted on 
the  prevalence  of  type  1  fimbriae  with  conflicting 
results. Several studies have found high expression of 
type 1 fimbriae amongst pyelonephritis, cystitis (67), 
or  faecal  isolates,  and  other  studies  have  reported 
equal  expression  of  this  pili  among  pyelonephritis 
and cystitis strains (60). These studies varied widely 
in  laboratory  culture  conditions,  age,  gender,  and 
geographical  location  of  subjects  which  are  likely 
factors involved in varied results. The switch-phase 
variation  with  P-pili  could  be  responsible  for  the 
differential  production  of  these  fimbriae  amongst 
cystitis  and  pyelonephritis  strains,  and  may  be 
responsible  for  variable  expression  amongst  body 
sites and studies (67). The role of switch-phase of 
type 1 fimbriae in septicaemia is not well studied. 
Amongst  E.  coli  strains  carrying  capsular  antigen 
K1,  type  1  fimbriae  mutants  with  phase  lock  ‘on’ 
have  been  found  to  be  more  pathogenic  during 
meningitis  than  those  with  phase  lock  ‘off’  (68). 
Despite this, type 1 fimbriation has been shown to 
be  associated  with  decreased  bacteraemia  amongst 
neonatal rats (69). Variable expression of adhesins 
and other virulence factors enables bacteria to adjust 
to  different  environments  encountered  during  the 
infection process (56, 64).
Several  allelic  variations  of  the  fimH  gene  have 
been identified, with at least three phenotypes having 
slightly different binding ability (70, 71). Pat least one 
study  has  suggested  low-binding  and  high-binding 
variations of fimH to mannose residues (70). In this 
study approximately 80% of bacteria from the large 
intestine of healthy humans expressed low-binding to 
mannose, whereas 70% of bacteria isolated from UTI 
expressed high-binding to mannose (70). Although 
type  1  fimbriae  are  found  amongst  a  majority  of 
commensal  and  pathogenic  E.  coli  strains,  allelic 
variations may exist between these two groups. 
Whilst type 1 fimbriae have an important role during 
colonisation of the UT, their role in colonization of 
the GI tract is uncertain (31, 43, 72). These fimbriae 
are  frequently  found  amongst  faecal  flora  and  are 
thought to be important for E. coli colonisation of the 
GI tract (45, 73). 
fimH is also able to attach to different cell types 
such  as  erythrocytes  and  macrophages,  however 
attachment  is  thought  to  occur  through  different 
mechanisms than epithelial cells (75). These fimbriae 
encourage adherence to phagocytes and subsequent 
phagocytosis  (24).  Once  phagocytosed,  type  1 
fimbriated  bacteria  can  survive  within  vacuoles  as 
long as they are unopsonised (76). This remarkable 
ability helps bacteria to overcome host defences and 
persist to cause disease.
The GI tract has a range of protective defences, 
of which sIg A is an important host defence against 
enteric  bacteria  (77).  GI  epithelial  cells  secrete 
sIg A  in  mucous,  which  bind  mannose-containing 
oligosaccharides and agglutinate bacteria in the gut 
to prevent epithelial cell adherence and penetration of 
the intestinal barrier. Mucin and sIgA may contribute 
to this process by binding type 1 fimbriae and trapping 
bacteria in mucous (77). Production of a biofilm by 
commensal bacteria helps prevent pathogenic bacteria 
from adhering to and translocating the GI epithelial 
barrier (77). Type 1 fimbriae have also been shown 
to  be  important  for  the  formation  of  intracellular 
bacterial communities, which have similar functions 
to biofilms (61). 
P-pili
Another  important  adhesion  for  UPEC  is 
pyelonephritis-associated pili, known as P-pili. P-pili 
are  the  second  most  common  adhesion  in  UPEC 
strains,  after  type  1  fimbriae  (24).  These  pili  are 
associated  with  UTI  and  pyelonephritis,  and  have 
been isolated from more than 80% of pyelonephritis 
causing strains (78). P-pili are assembled by proteins 
from a pap gene cluster composed of subunits papE, 
papF, papG, papA, papH, papC. Other pap genes 
are  important  for  fimbriae  assembly  but  are  not 
directly related to adhesion, such as papD which is 
responsible for stabilising translocation (6). papB is 
involved in regulating expression of type 1 fimbriae, 
as previously discussed (56, 64). 
P-pili are common VGs of E. coli strains belonging 
to phylogenetic groups B2 and D, and are regularly 
found among strains that cause UTI (38, 79). While 
type 1 fimbriae are important for initial infection of 
the lower UT, P-pili are involved in colonisation of the 
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suggests that type 1 fimbriae and P-pili are inversely 
regulated, with individual bacteria expressing only 
one type of fimbriae sequentially (64). Regulation of 
genes appears to be related to pathogenesis by enabling 
sequential colonisation of different UT tissues (80, 
81). Hence, both fimbriae play an important role in 
the  survival  and  pathogenesis  of  UPEC,  firstly  in 
colonisation of the GI tract, and then invasion of the 
UT (38, 43, 73, 74). 
P-pili  were  firstly  recognised  by  the  ability  to 
agglutinate  human  type  O  erythrocytes  without 
inhibition by mannose, distinguishing it from type 1 
fimbriae (6). It has been shown that a common P blood 
group antigen glycosphingolipid with a lipid moiety 
and carbohydrate chain to be the receptor for P-pili, 
α-D-Gal-(1→4)-β-D-Gal (Gal-Gal moiety) (82). This 
antigen is present in glycoproteins in humans and is 
found abundantly on the surface of epithelial cells 
lining  the  UT  (82).  The  presence  of  this  receptor 
on epithelial cells of the GI tract has not been fully 
investigated but it has been shown that resident E. 
coli strains of healthy adults contain a high rate of 
P-piliated E. coli strains (31). Attachment of P-pili to 
the receptor leads to the release of ceramide, acting as 
an agonist of Toll-like receptor 4, activating immune 
cell response (83). Epithelial cell activation leads to 
the production of cytokines and chemokines, such as 
interleukin (IL)-6, IL-8 and neutrophils (84). This in 
turn leads to the development of local inflammation 
and pain associated with UTI (84). P-pili expression 
of asymptomatic UTI has been found to be less than 
cystitis and pyelonephritis causing strains (85). Gal-
Gal moiety receptors are found in larger amounts in 
renal glycolipids than those from shed uroepithelial 
cells,  accounting  for  P-pili  association  with 
pyelonephritis. Receptor density (Gal-Gal moiety) on 
human uroepithelial cells are equal amongst men and 
women (24), suggesting other factors are important 
for increased UTI incidents among women. 
Unlike type 1 fimbriae, P-pili do not adhere freely 
to human polymorphonuclear leukocytes (hPMNLs), 
given that these cells only produce small amounts of 
Gal-Gal receptors (83).  In strains that also express 
type 1 fimbriae, P-pili may defend hPMNLs from 
adhering to and destroying the bacterium (6). 
Healthy humans are believed to have a reservoir of 
ExPEC strains, belonging to phylogenetic group B2, 
and to a lesser extent, group D, which have superior 
ability to survive and persist in the gut of humans (86), 
and can spread to cause disease (87). Interestingly, it 
has been suggested that P-pili expression enhances 
colonisation in the GI tract (31, 38, 73, 88). Wold et al 
(31) studied the prevalence of E. coli strains carrying 
this VG among the resident strains of the gut in healthy 
individuals and found a majority carried P-pili. Based 
on these results, it has been suggested that P-pili have 
evolved in E. coli strains to promote their persistence 
in the gut by attaching to Galα1g4Galß-containing 
receptors on gut epithelial cells (73).  Wold et al (74) 
also found type 1 fimbriae bound to colonic cells and 
to a substance loosely associated to the epithelium, 
however, P-pili only bound to the loosely associated 
substance and not the colonic cells (74). Continuous 
shedding of epithelial cells in the large intestine with 
Gal-Gal receptors may provide a niche for bacteria 
containing adhesions to establish colonisation within 
the  gut  (74).  Gal-Gal  binding  strength  to  the  UT 
epithelium is greater than that to colonic epithelial 
cells,  and  remains  stronger  after  repeat  washes, 
indicating that P-pili are well adapted for adherence 
in the UT. The dominance of these clones in the GI 
tract, and the presence of VGs are contributing factors 
of UTI (38). This suggests that colonic E. coli strains, 
which are persistent in the GI tract, have mechanisms 
associated with UTI that may be involved in early 
colonisation of the urethra (31, 73, 79, 86).  
Resident strains of E. coli in infants, school girls, and 
young women commonly belong to the phylogenetic 
group B2 (79, 86, 90) and express P-pili and type 1 
fimbriae more commonly than transient strains (86). 
For infants (aged 3 days to 12 months) half of these 
resident commensal B2 strains carried papC genes, 
which is believed to lead to persistence within the 
GI tract (79, 86). Zhang and co-workers found P-pili 
amongst  young  women  (aged  18  –  39  years)  was 
strongly associated with phylogenetic groups B2 and 
D (90). However group B2 had two distinct subgroups 
with  differing  levels  of  pathogenicity.  Zhang’s 
findings  suggest  that  healthy  adults  are  capable 
of  carrying  B2  strains  however  with  less  virulent 
subclasses than UTI isolates (90). Contrary to these 
findings, Schlager et al (89) found in healthy young 
girls (aged 3 to 6 years), resident strains with P-pili 
were not associated with UTI, despite clones of non-
dominant strains with P-pili present in the UT.  This 
was based on the findings that dominant clones in the 
GI tract varied weekly and did not reflect those in the 
urine, hypothesising that UTI strains are in the gut for 
only a short period. These results differ from studies 
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representing the same urine clone however the study 
design only included one faecal sample at the time of 
UTI (38). Further studies have found dominant clones 
of the faecal flora are more likely to spread to the UT 
(38, 89, 90). Incidents and pathogenesis of male UTI 
are not as frequently studied as females (91). 
P-pili  mediate  binding  to  epithelial  layers 
containing  Galα1g4Galß  through  the  use  of  the 
adhesion  molecule  papG  located  at  the  tip  of  the 
pilus (92, 93). There are three types of papG, each 
with slightly differing binding ability, these are papG 
allele I, papG allele II, and papG allele III (92, 93). 
The prevalence of papG allele I is debated, with some 
authors concluding it is uncommon and rarely found 
in  humans  (93),  whilst  others  report  its  presence 
amongst uropathogenic isolates (94). PapG allele II 
binds to globoside, which is located in the human 
kidney (95) and is more commonly associated with 
acute  pyelonephritis.  Animal  model  studies  have 
found that papG allele II enhances early colonisation 
of the kidney, however due to host immune defences, 
infection was not maintained (93). Cystitis is more 
commonly  associated  with  papG  allele  III  .  The 
association of papG allele III with cystitis but not 
pyelonephritis or bacteraemia may be indication that 
this papG variant is not sufficient for invasion of the 
bloodstream in non-compromised hosts (93). A study 
by Otto et al indicates that whilst papG allele II was 
associated  with  healthy  women  of  all  ages,  papG 
allele  III  was  more  common  in  men  (96),  though 
this  study  had  a  small  sample  size  for  male  UTI. 
During bacteraemia, papG allele II has shown to be 
associated with E. coli urosepsis, and papG allele III 
associated typically with compromised hosts such as 
those with immunosuppression or UT abnormalities 
(93). Furthermore, papG allele II has been identified 
as  the  predominant  variant  in  E.  coli  bacteraemia 
(93). Limited information is available on the role of 
papG variants for intestinal persistence, except that 
papG class I and II recognise the same receptors in 
the small intestine and presumably colonic proteins 
loosely associated with epithelial cells (97).
haemolysin 
Alpha haemolysin is a pore-forming toxin secreted 
by pathogenic E. coli to lyse erythrocytes and human 
renal  epithelial  cells  (98).  Lyses  of  erythrocytes 
releases iron which can be utilised through siderophore 
systems, hence the production of haemolysin is often 
regulated by iron availability. Haemolysin is toxic to 
many cells, leading to inflammation, tissue damage, 
and disruption of phagocyte function (24, 98). Alpha 
haemolysin is encoded chromosomally by the gene 
hlyA,  compared  to  animals  which  are  encoded  in 
plasmids  with  differing  nucleotide  sequences  (17). 
Unlike other toxins, hlyA gene is expressed without 
cleavage of peptides or cellular lysis (99). Haemolysin 
is most active during log phase of growth however 
activity declines when bacteria reach stationary phase 
despite continued cell production. This decrease is 
mainly due to toxic effects of excessive production 
to E. coli (99). Haemolysin production is increased 
during times of low iron concentration, and decreased 
in high iron situations (100). 
Haemolysin  is  seen  in  E.  coli  strains  associated 
with upper UTIs such as pyelonephritis, and is more 
common amongst invasive uropathogenic strains than 
healthy faecal isolates (24). It has been reported that 
an average 12% of faecal E. coli produce haemolysin, 
with similar results supported by other authors (101). 
Haemolysin  producing  strains  are  more  prevalent 
amongst  hosts  without  immune  compromising 
conditions such as renal scarring or pregnancy (24).
Cytotoxic necrotising factor 
Similar  to  α  -haemolysin,  cytotoxic  necrotising 
factor 1 (CNF1) is also encoded chromosomally by 
cnf1, with both toxins often co-expressed in UPEC 
strains (24). CNF1 targets the Rho family of GTP-
binding  proteins  and  induces  actin  cytoskeleton 
reorganisation, leading to apoptosis, which facilitates 
bacterial invasion into deeper tissue layers of the UT 
(102, 103). This process enables bacteria to persist 
within the UT (104). CNF1 is not as well understood 
as other UPEC virulence factors. Some authors have 
reported  CNF1  production  to  promote  progressive 
infection (104-106), whereas others have suggested 
no impact within the UT (107). These differences may 
be attributable to rat models (106), cell lines (105), 
and  human  models  (107).  Haemolysin  and  CNF1 
are strongly associated with phylogenetic group B2, 
with a stronger association amongst UTI strains than 
faecal isolates (90, 108, 109).
Siderophores 
Iron  is  essential  for  normal  bacteria  metabolism 
(110). Free iron in human hosts is limited and not 
easily accessible to bacteria. Iron in the body is usually 
found  as  haemoglobin  and  heme  (111).  Bacterial 
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hypoferremia to further reduce iron availability (112).   
During infection, the body reduces the amount of iron 
available to bacteria, decreasing iron absorption from 
the  gut  and  storing  iron  intracellularly  (110).  The 
release of transferrin tightly binds free iron, limiting 
the availability of iron for bacteria. In response to 
times of limited iron availability, some bacteria release 
iron chelators known as siderophores, which bind to 
iron with high affinity (110). There are many types 
of  siderophores  which  function  in  different  ways, 
some work to scavenge iron, whilst others compete 
with host defences to release iron from transferrin and 
lactoferrin (110). Iron is transported into the cell via 
outer membrane receptor proteins on the surface of 
the bacterium specific for each siderophore (110). 
In E. coli, ferric aerobactin receptor is encoded by 
the gene iutA. Aerobactin has been strongly associated 
with  pyelonephritis,  cystitis,  and  bacteremia  as 
opposed  to  asymptomatic  bacteriuria  or  faecal 
strains (24). Aerobactin has been associated with 45 
– 78% of UPEC strains (17, 113), with an increased 
association with bacteremic strains (113). Aerobactin 
is also associated with persistence in the GI tract, and 
is more common amongst resident than transient E. 
coli strains hence it may give a competitive advantage 
for survival and persistence in the GI tract (79, 88). 
As previously discussed, haemolysin also plays an 
important role for iron acquisition (114). It has been 
suggested as an alternative iron acquisition method, 
with clinical studies finding blood isolates lacking 
aerobactin  were  in  fact  positive  for  haemolysin 
production (114). Another identified iron siderophore 
is  iroNE.coli.  This  catecholate  siderophore  gene  is 
associated with pathogenesis of UPEC and is often 
coupled with other VGs (115).
Capsular polysaccharide
Capsules  are  mainly  a  polysaccharide  structure 
covering bacteria which acts to protect the bacterium 
from the host immune system (6). Capsules enhance 
serum survival, and help to facilitate bacteria to avoid 
O antigen detection and hence bacterial phagocytosis 
by hPMNLs (116). 
The production of capsules, mainly K1 and K5, are 
more commonly seen amongst resident strains of the 
gut, with capsular antigen K5 recognised to enhance 
gut colonisation (21, 117). Similarly, capsular antigen 
K1 has been shown to efficiently colonise the large 
intestine (72), with greater frequency amongst adults 
than  infants.  Whilst  capsule  synthesis  is  common 
amongst  faecal  isolates,  synthesis  is  significantly 
higher amongst UPEC strains (118). In the UT, capsules 
help  to  enhance  survival  by  avoiding  phagocytosis 
(116). E. coli strains expressing K1 capsule are the 
major  cause  of  Gram-negative  bacteraemia  and 
meningitis  in  neonates  and  have  been  reported  in 
E.coli strains causing cystitis (119). 
SuRVIVAL Of uPEC In ThE guT
Bacterial colonisation of the large intestine is the 
first stage in the development of enteric, urinary and 
systemic infections (72). Resident strains are those 
which are present in the gut from months to years, 
whereas transient strains are present for a short period 
of  time,  usually  days  to  weeks  (73,  86).  Resident 
strains are able to adhere and colonise the gut, and 
mostly constitute the dominant clones in the GI tract. 
Some studies have found resident strain commonly 
belong to phylogenetic group B2 and carry a number 
of  VGs  (79),  whereas  others  found  a  majority 
belonged to commensal phylogenetic groups A and 
B1 (38, 120).  
To survive the human GI tract, bacteria must evade 
host  defences,  acquire  nutrients  for  survival,  and 
competitively compete with other microflora (1, 10). 
Some VGs play a dual role to enhance colonisation 
of the GI tract and cause infection (38, 121). Bacteria 
with  adhesin  molecules  specific  to  gut  epithelium 
have  therefore  a  better  chance  to  colonise  the  GI 
tract.  P-pili  contribute  to  colonisation  of  the  gut, 
with resident strains having higher expression than 
transient strains (31, 73, 74, 79). Studies of healthy 
adults have found up to 50% of E. coli strains carry 
P-pili (121, 122). However these results vary widely 
and may be attributable to geographical and lifestyle 
differences (122). Type 1 fimbriae are also believed 
to  enhance  colonisation  of  E.  coli  in  the  GI  tract 
(74). Other VGs such as the aerobactin and capsule 
synthesis may also contribute to persistence in the 
large intestine (88). Contrary to the production of VGs 
for enhanced colonisation of the GI tract, Siitonen 
(101) found a low VGs profile amongst faecal E. coli 
isolates, leading to the conclusion that the gut is not 
a reservoir for infection. However, this has not been 
found  by  other  researchers,  with  many  supporting 
VGs enhancing colonisation of intestinal E. coli (73, 
74, 79, 93, 121). This inconsistency in results suggests 
other factors influence the population structure of E. 
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gut as a source of uTI
The gut is a common source of bacteria causing 
UTI. These bacteria can survive and persist in the 
gut from a few days to many years (10, 79). The 
finding that E. coli strains causing UTIs have been 
consistently isolated from the faecal flora of the same 
host (38, 45) strongly supports the gut-origin of UTIs. 
Intestinal E. coli strains causing UTI normally carry 
VGs necessary for colonisation of the UT and mainly 
belong to phylogenetic group B2 (90). Jantunen et al 
(50) found E. coli strains harbouring papG genes were 
the major facultative flora of the gut in children with 
urosepsis (aged 1 – 24 months). The way in which these 
strains come to inhabit the gut is not well established, 
with ingestion of contaminated poultry proposed as a 
source of UPEC strains (12, 123). Furthermore, birds 
have been suggested as reservoir of UPEC although 
additional reservoirs are likely to exist (124).
uPEC and septicaemia
In complicated cases of UTI or in compromised 
hosts, a simple UTI can lead to a serious infection 
known as septicaemia. From the kidneys, bacteria can 
enter the blood stream to cause sepsis (125). Urosepsis 
is  the  term  given  to  patients  with  UTI  associated 
sepsis, with the kidney believed to be the source of 
septicaemia. Studies into the incidents of urosepsis 
vary, with one study finding 5.9% of sepsis incidents 
originating from UTI (126), and another reporting a 
majority at 58.3% (127). Once bacteria have entered 
the  blood  they  can  infect  other  body  organs  to 
cause multiple organ failure, shock, and death (48, 
49).  Increased  bacterial  densities  also  increase  the 
likelihood of a strain colonising the opening of the 
urethra to cause UTI. In urosepsis, E. coli is assumed 
to move from the UT and kidney to the blood. The gut 
has also been established as a reservoir of extraintestinal 
E.  coli, with patients  experiencing  UTI,  septicaemia, 
urosepsis or meningitis typically carrying strains with 
VGs amongst faecal flora (39, 128).  Commensal  and 
less virulent UPEC strains have been shown to cause 
disease  in  immunodeficient  hosts  as  opposed  to 
uncompromised hosts (17). Therefore, in elderly people, 
these bacteria have a better ability to translocate to the 
blood directly from GI tract rather than the UT.
EVOLuTIOn  Of  uPEC  And  COnCLudIng 
REMARKS
It is widely accepted that UPEC strains originate 
from faecal flora, however whether their pathogenesis 
is due to higher prevalence within the faecal flora, 
or the acquisition of VGs, is widely debated (129). 
The “prevalence theory” holds that strains causing 
infection  are  predominant  within  the  faeces, 
increasing the likelihood of these strains colonising 
the opening of the UT to cause UTI. This is opposed 
to the “special pathogenicity theory” based on the 
selective advantage of E. coli VGs specifically for 
infection of extra-intestinal sites (129). Irrespective 
of the evolutionary influences in the development of 
these VGs, UPEC are well developed for survival in 
extra-intestinal  sites  such  as  the  UT.  Furthermore, 
evidences  suggest  that  VGs  which  contribute  to 
fitness within the UT are likely to enhance GI tract 
colonisation  (31,  85).  Intestinal  E.  coli  amongst 
infants, girls, and young women in health and during 
UTI has been widely studied, however; comparisons 
between genders and elderly individuals are limited. 
A review of the existing literature indicates that E. 
coli population structures between young adults and 
elderly, and genders, could be a predisposing factor to 
UTI with the GI tract being an established reservoir of 
infection. Furthermore, E. coli populations amongst 
elderly with weakening immune systems may be an 
important predisposing factor to disease, especially 
amongst hospitalised patients. Further researches are 
needed before these questions can be fully answered.   
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